Treatment-free remission after two-year consolidation therapy with nilotinib in patients with chronic myeloid leukemia: STAT2 trial in Japan-Reference-Cited by-同舟云学术

Treatment-free remission after two-year consolidation therapy with nilotinib in patients with chronic myeloid leukemia: STAT2 trial in Japan

Published:2018-07-05 Issue:11 Volume:103 Page:1835-1842
ISSN:0390-6078
Container-title:Haematologica
language:en
Short-container-title:Haematologica

Author:

Takahashi Naoto,Nishiwaki Kaichi,Nakaseko Chiaki,Aotsuka Nobuyuki,Sano Koji,Ohwada Chikako,Kuroki Jun,Kimura Hideo,Tokuhira Michihide,Mitani Kinuko,Fujikawa Kazuhisa,Iwase Osamu,Ohishi Kohshi,Kimura Fumihiko,Fukuda Tetsuya,Tanosaki Sakae,Takahashi Saori,Kameoka Yoshihiro,Nishikawa Hiroyoshi,Wakita Hisashi

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discontinuation of Tyrosine Kinase Inhibitor Therapy and Treatment Free Remission (TFR) in Chronic Myeloid Leukemia: Successful Achievement of TFR in More Than Two-Third of Patients in a Real-World Practice;Clinical Lymphoma Myeloma and Leukemia;2024-08

2. A Higher Neutrophil Count Is Associated with Favorable Achievement of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Who Received Second Generation Tyrosine Kinase Inhibitor as Frontline Treatment;Clinics and Practice;2024-06-21

3. Treatment free remission (TFR) after second-generation tyrosine kinase inhibitors (2G-TKIs) treatment in chronic myeloid leukemia (CML): from feasibility to safety;Expert Opinion on Drug Safety;2024-06-17

4. Treatment-Free Remission in Chronic Myeloid Leukemia;Journal of Clinical Medicine;2024-04-27

5. Measurable residual disease (MRD)-testing in haematological and solid cancers;Leukemia;2024-04-18